A presumed case of Darbepoetin‐induced myocardial infarction in the patient with MDS‐RARS. Issue 4 (18th February 2020)

• Record Type: Journal Article
• Authors: Zafar, Aneeqa Ahsan; Kouides, Peter
• Is Part Of: Clinical case reports. Volume 8:Issue 4(2020)
• Page Start: 658
• Page End: 660
• Publication Date: 2020-02-18
• Subjects: acute coronary syndrome -- anemia with ringed sideroblasts -- clonal hematopoiesis of indeterminate potential -- erythropoietin‐stimulating agents -- myelodysplastic syndromes; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.2728
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: Our case is only the 2nd such reported case of atherothrombosis from ESAs and highlights the increased risk of cardiovascular events in patients receiving erythropoietin‐stimulating agents specially patients with underlying MDS where targeting a lower hemoglobin goal and optimizing other cardiovascular risk factors might be beneficial in preventing future cardiovascular mortality. Abstract : Our case is only the 2nd such reported case of atherothrombosis from ESAs and highlights the increased risk of cardiovascular events in patients receiving erythropoietin‐stimulating agents specially patients with underlying MDS where targeting a lower hemoglobin goal and optimizing other cardiovascular risk factors might be beneficial in preventing future cardiovascular mortality.